ReviewPharmaceuticals (Basel, Switzerland)2022

Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery.

Zheng Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.